The process used to produce RDTC New Drug Evaluations (NDEs) is accredited by NICE. This means you can be assured that our NDEs are high quality and evidence-based.
Due to the time limited nature of NDEs they are published with the expectation that they will not be routinely scheduled for review. In view of the continued emergence of new evidence, readers are recommended to re-check the biomedical literature after 18 months beyond the publication date of each NDE
For full details of our publication process see the RDTC New Drug Evaluation process manual.
NICE has accredited the process used by the Regional Drug and Therapeutics Centre to produce New Drug Evaluations. Accreditation is valid for 5 years from 7 March 2017.
For more information visit www.nice.org/accreditation